Spots Global Cancer Trial Database for endometrial adenosquamous carcinoma

Every month we try and update this database with for endometrial adenosquamous carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT00820898	Endometrial Ade... Endometrial Ade... Endometrial Cle... Recurrent Uteri...	Gemcitabine Hyd...	18 Years -	GOG Foundation
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer	NCT01935934	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Ser... Metastatic Endo... Recurrent Uteri... Stage IV Uterin... Stage IVA Uteri... Stage IVB Uteri... Uterine Corpus ...	Cabozantinib S-... Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer	NCT01005329	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Bevacizumab Carboplatin Cisplatin Intensity-Modul... Paclitaxel	18 Years -	National Cancer Institute (NCI)
Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus	NCT00064025	Endometrial Ade... Endometrial Ade... Endometrial End... Recurrent Uteri... Stage I Uterine... Stage II Uterin... Stage III Uteri... Stage IV Uterin...	Laboratory Biom... Medroxyprogeste... Therapeutic Con...	18 Years -	GOG Foundation
Gemcitabine in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT00820898	Endometrial Ade... Endometrial Ade... Endometrial Cle... Recurrent Uteri...	Gemcitabine Hyd...	18 Years -	GOG Foundation
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer	NCT01935934	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Ser... Metastatic Endo... Recurrent Uteri... Stage IV Uterin... Stage IVA Uteri... Stage IVB Uteri... Uterine Corpus ...	Cabozantinib S-... Laboratory Biom... Pharmacological...	18 Years -	National Cancer Institute (NCI)
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer	NCT01005329	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Bevacizumab Carboplatin Cisplatin Intensity-Modul... Paclitaxel	18 Years -	National Cancer Institute (NCI)
Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer	NCT00006011	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial End... Endometrial Ser... Stage III Uteri...	Doxorubicin Hyd... Cisplatin Filgrastim Pegfilgrastim Paclitaxel	-	GOG Foundation
Intraperitoneal Paclitaxel, Doxorubicin Hydrochloride, and Cisplatin in Treating Patients With Stage III-IV Endometrial Cancer	NCT00575952	Endometrial Ade... Endometrial Cle... Endometrial Mix... Endometrial Ser... Endometrial Squ... Endometrial Und... Recurrent Uteri... Stage IIIA Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Cisplatin Doxorubicin Hyd... Filgrastim Paclitaxel Pegfilgrastim	-	GOG Foundation
Cediranib Maleate in Treating Patients With Recurrent or Persistent Endometrial Cancer	NCT01132820	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Recurrent Uteri...	Cediranib Malea... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Intensity-Modulated Radiation Therapy, Cisplatin, and Bevacizumab Followed by Carboplatin and Paclitaxel in Treating Patients Who Have Undergone Surgery for Endometrial Cancer	NCT01005329	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Stage IA Uterin... Stage IB Uterin... Stage II Uterin... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Bevacizumab Carboplatin Cisplatin Intensity-Modul... Paclitaxel	18 Years -	National Cancer Institute (NCI)
Akt Inhibitor MK2206 in Treating Patients With Recurrent or Advanced Endometrial Cancer	NCT01307631	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Recurrent Uteri...	Akt Inhibitor M... Laboratory Biom...	18 Years -	National Cancer Institute (NCI)
Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer	NCT01210222	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial End... Endometrial Ser... Endometrioid St... Recurrent Uteri...	Trebananib	18 Years -	GOG Foundation
Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer	NCT00977574	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Ser... Recurrent Uteri... Stage IIIA Uter... Stage IIIB Uter... Stage IIIC Uter... Stage IVA Uteri... Stage IVB Uteri...	Bevacizumab Carboplatin Ixabepilone Laboratory Biom... Paclitaxel Temsirolimus	18 Years -	National Cancer Institute (NCI)
Medroxyprogesterone in Treating Patients With Endometrioid Adenocarcinoma of the Uterine Corpus	NCT00064025	Endometrial Ade... Endometrial Ade... Endometrial End... Recurrent Uteri... Stage I Uterine... Stage II Uterin... Stage III Uteri... Stage IV Uterin...	Laboratory Biom... Medroxyprogeste... Therapeutic Con...	18 Years -	GOG Foundation
Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer	NCT00006011	Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial End... Endometrial Ser... Stage III Uteri...	Doxorubicin Hyd... Cisplatin Filgrastim Pegfilgrastim Paclitaxel	-	GOG Foundation
Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers	NCT02020707	Cervical Adenoc... Cervical Adenos... Cervical Adenos... Cervical Carcin... Cervical Squamo... Clinical Stage ... Endometrial Ade... Endometrial Cle... Endometrial End... Endometrial Mix... Endometrial Muc... Endometrial Ser... Endometrial Und... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Fallopian Tube ... Malignant Femal... Malignant Ovari... Malignant Ovari... Malignant Ovari... Malignant Ovari... Malignant Perit... Malignant Solid... Ovarian Carcino... Ovarian Clear C... Ovarian Endomet... Ovarian High Gr... Ovarian Mucinou... Ovarian Serous ... Ovarian Transit... Ovarian Undiffe... Platinum-Resist... Platinum-Resist... Platinum-Resist... Platinum-Sensit... Primary Periton... Primary Periton... Primary Periton... Primary Periton... Primary Periton... Unresectable Me... Uterine Corpus ...	Bevacizumab Laboratory Biom... Nab-paclitaxel Pharmacological...	18 Years -	Mayo Clinic

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: